Indication

Legionella pneumophila pneumonia

*Legionella pneumophila* pneumonia, commonly referred to as Legionnaires' disease, is an acute, potentially severe lower respiratory tract infection caused by the intracellular Gram-negative bacterium *Legionella pneumophila*. Read more about Legionella pneumophila pneumonia

75 drugs 64 manufacturers

Advertisement

Drugs that treat it

Common Legionella pneumophila pneumonia therapies.

Showing 1–9 of 75 drugs

Filter & compare in the drug finder →Opens the drug finder with Legionella pneumophila pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Legionella pneumophila pneumonia.

*Legionella pneumophila* pneumonia, commonly referred to as Legionnaires' disease, is an acute, potentially severe lower respiratory tract infection caused by the intracellular Gram-negative bacterium *Legionella pneumophila*.

It primarily affects adults with risk factors such as advanced age, tobacco use, chronic obstructive pulmonary disease, or immunocompromising conditions, and is typically acquired via the inhalation or aspiration of contaminated water aerosols.

Pathophysiologically, the organism proliferates within alveolar macrophages, inciting alveolar inflammation, consolidation, and impaired gas exchange.

Clinically, it manifests as high fever, dyspnea, and a cough that frequently progresses alongside prominent extrapulmonary manifestations, notably gastrointestinal symptoms, neurologic abnormalities, and hyponatremia.

Personalize your experience

Follow Legionella pneumophila pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it